Log in to access your PharmaMiles
and download the data
| Last Updated on PharmaCompass | Virtual Booth | Country | Holder | DMF No. | Subject | Submission Date | Status | Type | GDUFA DMF Review | GDUFA Review Date | GDUFA Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 28/03/2025 | Bellicum Pharmaceuticals |
U.S.A |
UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER | 27424 | AP1903 DRUG SUBSTANCE | 2013-08-14 | Active | II | N/A | ||
| 28/03/2025 | Poseida Therapeutics, Inc |
U.S.A |
POSEIDA THERAPEUTICS | 32053 | RIMIDUCID DRUG SUBSTANCE AND RIMIDUCID FOR INJECTION | 2018-04-30 | Active | II | N/A |
